(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 1. Spry and Csw/SHP-2 have opposing roles during RTK signaling.
(A) Csw, SHP-2 and Spry structures. Open bars, wild-type proteins. SH2
and phosphatase domains of Csw and SHP-2, and the T/SNEY amino acid motif and
cysteine-rich domain of Spry proteins are indicated. White gap in Csw
phosphatase domain indicates a non-conserved insertion. Mutant forms are
indicated below bars: activating mutations (green), inactivating and
dominant-negative mutations (red), and neutral mutations (black). myr,
N-terminal 90 residues of Src64 including myristylation site.
PO3, phosphotyrosine. (B-E) Effects of
spry loss of function and csw gain of function on tracheal
development. (B) Fluorescence micrograph of ends of two dorsal branches
(DB) from a control spry+ third instar w;
btl-GAL4, UAS-GFP larva expressing GFP throughout tracheal system.
Dorsal view, anterior upwards. Terminal cells (arrowheads) extend branches
anteriorly and laterally. (C) Same view of third instar w;
btl-GAL4, UAS-GFP; spry
5
larva showing extra terminal cells. (D) Same view of third instar
y,w; UAS-myr-csw/btl-GAL4,
UAS-GFP larva that expresses myristylated (activated) Csw throughout
developing tracheal system. Extra terminal cells are present as in C.
(E) Number of DB terminal cells per segment in genotypes shown in B-D.
Mean values (±s.e.m.): spry+ (2.2±0.04,
n=123 segments), spry
5
(3.8±0.1, n=133), btl>myr-csw
(3.3±0.06, n=210). (F-H) Effect of spry dose on
csw gain- and loss-of-function phenotypes in eye development.
(F) Number of R7 cells per ommatidium in SE-myr-csw/+ flies
expressing myr-csw in developing eyes (black bars, n=293
ommatidia), and in SE-myr-csw/+;
spry
5/+ flies (white bars,
n=324). Wild type has one R7 cell per ommatidium. myr-csw
effect increased when spry dose was reduced. (G) Number of
outer photoreceptors per ommatidium in SE-cswG547E/+ flies
expressing dominant-negative CswG547E in developing eyes (black
bars, n=292) and in SE-cswG547E/+;
spry
5/+ flies (white bars,
n=329). Wild type has six outer photoreceptors per ommatidium. The
CswG547E effect was suppressed when spry dose was reduced.
(H) Number of outer photoreceptors per ommatidium in
SE-cswC583S/+ flies expressing dominant-negative,
substrate-trapping CswC583S protein in developing eyes (filled
bars, n=582), and in
SE-cswC583S/spry
5 flies (open
bars, n=604). CswC583S effect was not suppressed when
spry dose was reduced. (I,J) Effect of SHP-2 and Spry1 on FGF-induced
phosphorylation of ERK2 in HEK293 cells. (I) HEK293 cells were
transfected with plasmid expressing ERK2 with HA epitope (ERK2-HA) and empty
vector or vector expressing Spry1 with FLAG epitope (FL-Spry1),
dominant-negative SHP-2C459S or wild-type SHP-2 as indicated. After
transfection, bFGF was added for 30 minutes to activate FGF pathway. (Top
panels) ERK2-HA immunoprecipitated (IP) from cell lysates with anti-HA
antiserum and analyzed on immunoblots with anti-dpERK to show diphosphorylated
(active) ERK2-HA or with anti-HA to show total ERK2-HA. (Bottom panels)
Immunoblots of whole cell lysates (WCL) probed with anti-FLAG to detect
FL-Spry1 or anti-SHP-2 to detect endogenous SHP-2 and SHP-2 from transfected
plasmids. Similar results were obtained in three experiments. (J)
Effect of Spry1 and dominant negative SHP-2C459S on kinetics of
ERK2 activation by FGF. As in I, except ERK2 analysis was carried out at times
indicated after FGF addition. Similar results were obtained in two
experiments.